Back to Search
FRANK PALELLA, MD
MD
Infectious Disease Physician
NPI: 1952329021IndividualAccepts Medicare
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
CMS Specialties
PrimaryINFECTIOUS DISEASE
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Class of 1987
Research & Publications (20)
The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study.
PMID 19620160·Ann Intern Med·2009
4-observational
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
PMID 16878047·J Acquir Immune Defic Syndr·2006
4-observational
Anthropometrics and examiner-reported body habitus abnormalities in the multicenter AIDS cohort study.
PMID 14999638·Clin Infect Dis·2004
4-observational
Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata.
PMID 12693883·Ann Intern Med·2003
4-observational
Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients.
PMID 12172083·AIDS·2002
8-other
Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects.
PMID 19595354·Atherosclerosis·2010
8-other
Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART.
PMID 19601997·HIV Med·2009
4-observational
Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study.
PMID 19095683·J Antimicrob Chemother·2009
8-other
Heterologous fat transplantation for the treatment of HIV-related facial lipoatrophy.
PMID 19124830·Ann Intern Med·2009
5-case
Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project.
PMID 19236121·Drug Saf·2009
1-meta
Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy.
PMID 19339895·J Acquir Immune Defic Syndr·2009
8-other
Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: a substudy of the Multicenter AIDS Cohort Study.
PMID 19439092·AIDS Res Ther·2009
8-other
Duffy antigen polymorphisms do not alter progression of HIV in African Americans in the MACS cohort.
PMID 19454342·Cell Host Microbe·2009
4-observational
Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study.
PMID 18670218·AIDS·2008
4-observational
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.
PMID 18279104·J Interferon Cytokine Res·2008
3-trial
Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
PMID 18532884·Clin Infect Dis·2008
8-other
Antiretroviral therapy is associated with an atherogenic lipoprotein phenotype among HIV-1-infected men in the Multicenter AIDS Cohort Study.
PMID 18545156·J Acquir Immune Defic Syndr·2008
8-other
Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy.
PMID 17690571·AIDS·2007
4-observational
Immunophenotypic alterations in acute and early HIV infection.
PMID 17916441·Clin Immunol·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 680 N LAKE SHORE DR, SUITE 1000
CHICAGO, IL 60611 - Phone
- (312) 695-9797
Quick Facts
- NPI
- 1952329021
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile